Trials / Completed
CompletedNCT01864759
Phase I Endovenous Administration of Oncolytic Adenovirus ICOVIR-5 in Patients With Advanced or Metastatic Melanoma
Phase I Clinical Trial of Endovenous Administration of Conditionally Replicative Adenovirus ICOVIR-5 in Patients With Locally Advanced or Metastatic Melanoma
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 14 (actual)
- Sponsor
- Institut Català d'Oncologia · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The investigators will evaluate the safety of a single endovenous infusion of ICOVIR5 in adults with locally advanced and metastatic melanoma. ICOVIR5 consists in a conditionally replicative or oncolytic adenovirus.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | ICOVIR-5 |
Timeline
- Start date
- 2013-01-11
- Primary completion
- 2016-12-20
- Completion
- 2017-04-26
- First posted
- 2013-05-30
- Last updated
- 2017-08-29
Locations
1 site across 1 country: Spain
Source: ClinicalTrials.gov record NCT01864759. Inclusion in this directory is not an endorsement.